ACADIA Pharmaceuticals (NASDAQ:ACAD) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
ACADIA Pharmaceuticals missed estimated earnings by 12.5%, reporting an EPS of $-0.27 versus an estimate of $-0.24.
Revenue was up $9.75 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.17 which was followed by a 10.22% increase in the share price the next day.
Here's a look at ACADIA Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.26 | -0.31 | -0.53 | -0.47 |
| EPS Actual | -0.09 | -0.27 | -0.42 | -0.42 |
| Revenue Estimate | 127.75M | 126.15M | 111.63M | 123.20M |
| Revenue Actual | 131.61M | 115.22M | 106.55M | 121.01M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
